Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Liabilities (2019 - 2025)

Volitionrx's Total Liabilities history spans 9 years, with the latest figure at $42.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 19.68% year-over-year to $42.5 million; the TTM value through Dec 2025 reached $42.5 million, up 19.68%, while the annual FY2025 figure was $42.5 million, 19.68% up from the prior year.
  • Total Liabilities reached $42.5 million in Q4 2025 per VNRX's latest filing, roughly flat from $42.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $42.5 million in Q4 2025 to a low of -$31.2 million in Q1 2021.
  • Average Total Liabilities over 5 years is $24.4 million, with a median of $21.9 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: plummeted 505.26% in 2021, then soared 166.98% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $9.8 million in 2021, then skyrocketed by 119.3% to $21.4 million in 2022, then skyrocketed by 71.15% to $36.7 million in 2023, then dropped by 3.15% to $35.5 million in 2024, then rose by 19.68% to $42.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Total Liabilities are $42.5 million (Q4 2025), $42.4 million (Q3 2025), and $41.8 million (Q2 2025).